Centessa Pharmaceuticals PLC
F:260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Centessa Pharmaceuticals PLC
F:260
|
UK |
|
W
|
Wendel SE
XMUN:WIS
|
FR |
|
D
|
Dental Corporation PCL
SET:D
|
TH |
|
T
|
Thomson Reuters Corp
XMUN:TOC
|
CA |
|
Delivery Hero SE
F:DHER
|
DE |
|
RENERGEN Ltd
F:996
|
ZA |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
L
|
Louisiana-Pacific Corp
F:LP3
|
US |
|
S
|
Societe Generale SA
XMUN:SGE
|
FR |
|
V
|
Vinci SA
F:SQU
|
FR |
|
B
|
Basf Se
DUS:BAS
|
DE |
Wall St Price Targets
Price Targets Summary
Centessa Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
Centessa Pharmaceuticals PLC is 37.06 EUR with a low forecast of 29.48 EUR and a high forecast of 54.29 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Centessa Pharmaceuticals PLC's stock price target?
Price Target
37.06
EUR
According to Wall Street analysts, the average 1-year price target for
Centessa Pharmaceuticals PLC is 37.06 EUR with a low forecast of 29.48 EUR and a high forecast of 54.29 EUR.
What is the Revenue forecast for Centessa Pharmaceuticals PLC?
Projected CAGR
87%
The compound annual growth rate for Revenue over the next 8 years is 87%.